Library / Laws / 118th Congress / House Bills / H.R. 1620
H.R. 1620
To promote affordable access to evidence-based opioid treatments under the Medicare program and require coverage of medication assisted treatment for opioid use disorders, opioid overdose reversal medications, and recovery support services by health plans without cost-sharing requirements.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2023-03-17 | 5.5K | ⠃⠗⠋ |